Skip to content

US · CVSA · EDUCATION & TRAINING SERVICES

Covista Inc. (CVSA) intrinsic value and stock valuation

$109.13as of 2026-11-21 · Mkt cap 4.8B

Data updated · price as of 2026-11-21

UndervaluedIC value is 20–50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Covista Inc. DCF and intrinsic value

InvestorsCraft values CVSA with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from CVSA’s statements →

Covista Inc. Graham Number

Graham Number: $73.87d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Consumer Defensive · Education & Training Services Chicago, IL 60606 covista.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$1.79B+11.2% 5y CAGRd
20112025
Net income
$232.7M+2.8% 5y CAGRd
20112025
Free cash flow
$287.6M+33.4% 5y CAGRd
20112025
Total equity
$1.43B+1.8% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$1.79B$1.58B$1.45B$1.38B$906.9M
Operating income$341.5M$217.1M$226.3M$155.6M$156.5M
Net income$232.7M$136.8M$96.9M-$-162.49M$76.9M
EPSd$6.07M$3.39M$2.13M-$-3.36M$1.49M
Operating cash flow$337.9M$295.8M$191.9M$10.6M$192.2M
Capital expenditure-$-50.33M-$-48.89M-$-26.01M-$-31.05M-$-39.88M
Free cash flow$287.6M$246.9M$165.9M-$-20.45M$152.3M
Total assets$2.75B$2.74B$2.81B$3.03B$3.08B
Total debt$774M$847.9M$896.2M$1.07B$1.3B
Net debt$574.4M$628.6M$624M$719.8M$824.3M
Total equity$1.43B$1.37B$1.46B$1.49B$1.3B
Cash and short-term investments$199.6M$219.3M$272.2M$347M$476.4M
Income statement
20252024202320222021
Revenue$1.79B$1.58B$1.45B$1.38B$906.9M
Cost of revenue$771.4M$698.6M$676.7M$729.9M$446.9M
Gross profit$1.02B$886.1M$774.1M$651.9M$460M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$671.1M$614.5M$576M$566.5M$292.5M
Other expenses$4.21M$54.6M-$-28.24M-$-70.13M$11M
Operating expenses$675.3M$669.1M$547.8M$496.4M$303.5M
Cost and expenses$1.45B$1.37B$1.22B$1.23B$750.4M
Interest income$8.22M$9.18M$10.7M$3.82M$4.09M
Interest expense$52.3M$63.7M$63.2M$98.9M$42.8M
Depreciation and amortization$84.5M$75.3M$151.1M$186.6M$84.5M
Ebitda$427.3M$347M$326.3M$264.5M$210.8M
Operating income$341.5M$217.1M$226.3M$155.6M$156.5M
Total other income/expenses, net-$-43.03M-$-53.12M-$-114.3M-$-207.07M-$-73.09M
Income before tax$298.5M$163.9M$112M-$-51.49M$83.4M
Income tax expense$65.8M$26.2M$10.3M-$-15.54M$13.1M
Net income$232.7M$136.8M$96.9M-$-162.49M$76.9M
Weighted average shares outstanding$37.1M$40M$44.8M$48.4M$51.3M
Weighted average diluted shares outstanding$38.3M$40.3M$45.6M$48.4M$51.7M
Balance sheet
20252024202320222021
Cash and short-term investments$199.6M$219.3M$272.2M$347M$476.4M
Net receivables$146.2M$126.8M$102.8M$81.6M$43M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$416.2M$418.1M$480.3M$557.1M$1.51B
Property, plant and equipment, net$447.3M$425.3M$419.3M$467.9M$451.1M
Goodwill and intangible assets$1.73B$1.74B$1.77B$1.83B$447.7M
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$2.34B$2.32B$2.33B$2.47B$1.57B
Total assets$2.75B$2.74B$2.81B$3.03B$3.08B
Accounts payable$105M$102.6M$81.8M$57.1M$42.4M
Short-term debt$35.2M$31.4M$37.7M$50.8M$57M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$507.9M$487.7M$431.2M$423.7M$408.8M
Long-term debt$738.8M$816.4M$858.5M$1.02B$1.24B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$810.8M$884.6M$922M$1.12B$1.37B
Capital lease obligations$221.3M$199.1M$201.1M$227.8M$221.1M
Total liabilities$1.32B$1.37B$1.35B$1.54B$1.78B
Common stock$840K$830K$820K$820K$810K
Retained earnings$2.78B$2.54B$2.4B$2.31B$2.01B
Accumulated other comprehensive income (loss)-$-2.23M-$-2.23M-$-2.23M-$-2.23M-$-7.37M
Total equity$1.43B$1.37B$1.46B$1.49B$1.3B
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$774M$847.9M$896.2M$1.07B$1.3B
Net debt$574.4M$628.6M$624M$719.8M$824.3M
Cash flow statement
20252024202320222021
Net income$237.1M$136.8M$93.4M$311M$70M
Depreciation and amortization$90.5M$113.6M$160.2M$229.3M$87.2M
Stock-based compensation$41.6M$26M$14.3M$22.6M$12.8M
Change in working capital-$-148.99M-$-111.86M-$-134.34M-$-137.83M-$-23.57M
Accounts receivable-$-80.82M-$-76.36M-$-56.31M-$-41.39M$15.4M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$0.00$0.00$0.00$0.00$0.00
Net cash provided by operating activities$337.9M$295.8M$191.9M$10.6M$192.2M
Investments in property, plant and equipment-$-50.33M-$-48.89M-$-26.01M-$-31.05M-$-39.88M
Acquisitions, net$0.00$0.00$0.00-$-1.49B$0.00
Net cash used for investing activities-$-41.92M-$-47.85M$23.7M-$-551.8M-$-56.69M
Common stock issued$0.00$0.00$0.00$0.00$0.00
Common stock repurchased-$-227.32M-$-269.7M-$-127.72M-$-122.83M-$-104.21M
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-316.02M-$-301.8M-$-288.51M-$-424.48M$676.5M
Net change in cash-$-20.04M-$-53.87M-$-72.86M-$-965.68M$812.5M
Cash at end of period$201.2M$221.2M$275.1M$347.9M$1.31B
Operating cash flow$337.9M$295.8M$191.9M$10.6M$192.2M
Capital expenditure-$-50.33M-$-48.89M-$-26.01M-$-31.05M-$-39.88M
Free cash flow$287.6M$246.9M$165.9M-$-20.45M$152.3M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Covista Inc.

        Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor established the company in 1973, and its corporate headquarters are situated in Chicago, Illinois.

        CEO
        Stephen W. Beard
        Employees
        10.37K
        Beta
        0.62

        Explore

        Frequently asked questions

        What is the intrinsic value of Covista Inc. (CVSA)?

        Covista Inc. (CVSA) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is CVSA undervalued?

        CVSA trades at a price of $109.13 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.